Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects

Trial Profile

A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 21 Oct 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Otitis media
  • Focus Adverse reactions
  • Sponsors Otonomy [CEASED]

Most Recent Events

  • 03 Aug 2017 According to an Otonomy media release, results from this study were presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
  • 12 May 2017 According to an Otonomy media release, data will be presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
  • 04 Oct 2016 According to an Otonomy media release, additional results from this trial will be presented at the Otonomy Investor and Analyst Day on October 7 and at an upcoming medical conference.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top